Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.

Emrich IE, Brandenburg V, Sellier AB, Schauerte J, Wiedenroth J, Untersteller K, Lennartz CS, Seiler-Mussler S, Wagenpfeil S, Fliser D, Heine GH.

Am J Nephrol. 2019;49(3):203-211. doi: 10.1159/000497125. Epub 2019 Feb 26.

PMID:
30808827
2.

Erratum.

Untersteller K, Seiler-Mußler S, Mallamaci F, Fliser D, London GM, Zoccali C, Heine GH.

Nephrol Dial Transplant. 2019 Jan 21. doi: 10.1093/ndt/gfy408. [Epub ahead of print] No abstract available.

PMID:
30668741
3.

Author Correction: Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2019 Feb;15(2):121. doi: 10.1038/s41581-018-0099-y.

PMID:
30538326
4.

Plasma levels of the oxyphytosterol 7α-hydroxycampesterol are associated with cardiovascular events.

Fuhrmann A, Weingärtner O, Meyer S, Cremers B, Seiler-Mußler S, Schött HF, Kerksiek A, Friedrichs S, Ulbricht U, Zawada AM, Laufs U, Scheller B, Fliser D, Schulze PC, Böhm M, Heine GH, Lütjohann D.

Atherosclerosis. 2018 Dec;279:17-22. doi: 10.1016/j.atherosclerosis.2018.10.010. Epub 2018 Oct 17.

PMID:
30366187
5.

Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. Review. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121.

PMID:
30361677
6.

Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium.

Inker LA, Grams ME, Levey AS, Coresh J, Cirillo M, Collins JF, Gansevoort RT, Gutierrez OM, Hamano T, Heine GH, Ishikawa S, Jee SH, Kronenberg F, Landray MJ, Miura K, Nadkarni GN, Peralta CA, Rothenbacher D, Schaeffner E, Sedaghat S, Shlipak MG, Zhang L, van Zuilen AD, Hallan SI, Kovesdy CP, Woodward M, Levin A; CKD Prognosis Consortium.

Am J Kidney Dis. 2019 Feb;73(2):206-217. doi: 10.1053/j.ajkd.2018.08.013. Epub 2018 Oct 19.

PMID:
30348535
7.

In Reply.

Heine GH.

Dtsch Arztebl Int. 2018 Sep 14;155(37):606-607. doi: 10.3238/arztebl.2018.0606b. No abstract available.

8.

Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.

Zewinger S, Rauen T, Rudnicki M, Federico G, Wagner M, Triem S, Schunk SJ, Petrakis I, Schmit D, Wagenpfeil S, Heine GH, Mayer G, Floege J, Fliser D, Gröne HJ, Speer T.

J Am Soc Nephrol. 2018 Nov;29(11):2722-2733. doi: 10.1681/ASN.2018040405. Epub 2018 Oct 2.

PMID:
30279273
9.

Plasma FGF23 does not rise during physical exercise as a physiological model of sympathetic activation.

Emrich IE, Baier M, Zawada AM, Meyer T, Fliser D, Scharhag J, Heine GH.

Clin Res Cardiol. 2019 Mar;108(3):341-343. doi: 10.1007/s00392-018-1347-7. Epub 2018 Aug 8. No abstract available.

PMID:
30091082
10.

Corrigendum: FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?

Stöhr R, Schuh A, Heine GH, Brandenburg V.

Front Endocrinol (Lausanne). 2018 Jul 18;9:422. doi: 10.3389/fendo.2018.00422. eCollection 2018.

11.

FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?

Stöhr R, Schuh A, Heine GH, Brandenburg V.

Front Endocrinol (Lausanne). 2018 Jun 27;9:351. doi: 10.3389/fendo.2018.00351. eCollection 2018. Review. Erratum in: Front Endocrinol (Lausanne). 2018 Jul 18;9:422.

12.

L-Homoarginine and its AGXT2-metabolite GOCA in chronic kidney disease as markers for clinical status and prognosis.

Martens-Lobenhoffer J, Emrich IE, Zawada AM, Fliser D, Wagenpfeil S, Heine GH, Bode-Böger SM.

Amino Acids. 2018 Oct;50(10):1347-1356. doi: 10.1007/s00726-018-2610-y. Epub 2018 Jul 7.

PMID:
29982953
13.

HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients.

Untersteller K, Meissl S, Trieb M, Emrich IE, Zawada AM, Holzer M, Knuplez E, Fliser D, Heine GH, Marsche G.

J Lipid Res. 2018 Jul;59(7):1256-1265. doi: 10.1194/jlr.P085076. Epub 2018 May 22.

14.

Oral Anticoagulation in Chronic Kidney Disease and Atrial Fibrillation.

Heine GH, Brandenburg V, Schirmer SH.

Dtsch Arztebl Int. 2018 Apr 27;115(17):287-294. doi: 10.3238/arztebl.2018.0287.

15.

High-Dose Ferric Carboxymaltose in Patients With HFrEF Induces Significant Hypophosphatemia.

Stöhr R, Sandstede L, Heine GH, Marx N, Brandenburg V.

J Am Coll Cardiol. 2018 May 15;71(19):2270-2271. doi: 10.1016/j.jacc.2018.03.448. No abstract available.

PMID:
29747838
16.

Do plasma neprilysin activity and plasma neprilysin concentration predict cardiac events in chronic kidney disease patients?

Emrich IE, Vodovar N, Feuer L, Untersteller K, Nougue H, Seiler-Mussler S, Fliser D, Launay JM, Heine GH.

Nephrol Dial Transplant. 2019 Jan 1;34(1):100-108. doi: 10.1093/ndt/gfy066.

PMID:
29635392
17.

Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease.

Seiler-Mussler S, Limbach AS, Emrich IE, Pickering JW, Roth HJ, Fliser D, Heine GH.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):569-576. doi: 10.2215/CJN.06620617. Epub 2018 Mar 5.

PMID:
29507005
18.

Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease.

Untersteller K, Seiler-Mußler S, Mallamaci F, Fliser D, London GM, Zoccali C, Heine GH.

Nephrol Dial Transplant. 2018 Apr 1;33(4):653-660. doi: 10.1093/ndt/gfx197.

PMID:
29106648
19.

Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.

Emrich IE, Zawada AM, Martens-Lobenhoffer J, Fliser D, Wagenpfeil S, Heine GH, Bode-Böger SM.

Clin Res Cardiol. 2018 Mar;107(3):201-213. doi: 10.1007/s00392-017-1172-4. Epub 2017 Nov 3.

PMID:
29101459
20.

Hydration and contrast-induced kidney injury.

Schwarz V, Heine GH, Böhm M, Scheller B.

Lancet. 2017 Jul 29;390(10093):452. doi: 10.1016/S0140-6736(17)31815-9. Epub 2017 Jul 27. No abstract available.

PMID:
28792406
21.

Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients.

Heine GH, Rogacev KS, Weingärtner O, Marsche G.

Semin Dial. 2017 Sep;30(5):390-394. doi: 10.1111/sdi.12621. Epub 2017 Jun 19.

PMID:
28628255
22.

Reprint of: MicroRNA profiling of human intermediate monocytes.

Zawada AM, Zhang L, Emrich IE, Rogacev KS, Krezdorn N, Rotter B, Fliser D, Devaux Y, Ziegler-Heitbrock L, Heine GH.

Immunobiology. 2017 Jun;222(6):831-840. doi: 10.1016/j.imbio.2017.05.003. Epub 2017 May 31.

PMID:
28578934
23.

The systemic nature of CKD.

Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW, Fliser D, Fouque D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Parati G, Rossignol P, Wiecek A, London G; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA).

Nat Rev Nephrol. 2017 Jun;13(6):344-358. doi: 10.1038/nrneph.2017.52. Epub 2017 Apr 24. Review.

PMID:
28435157
24.

Letter to the Editor regarding Dounousi E et al. Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.

Schlitt A, Sester U, Sester M, Seiler-Mussler S, Brandenburg V, Schäffner E, Heine GH.

Eur J Clin Invest. 2017 Jun;47(6):468-469. doi: 10.1111/eci.12761. No abstract available.

PMID:
28415155
25.

Erratum.

Emrich IE, Heine GH.

Nephrol Dial Transplant. 2017 Jan 1;32(1):202. doi: 10.1093/ndt/gfw435. No abstract available.

PMID:
28391315
26.

Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH).

Sarafidis PA, Persu A, Agarwal R, Burnier M, de Leeuw P, Ferro CJ, Halimi JM, Heine GH, Jadoul M, Jarraya F, Kanbay M, Mallamaci F, Mark PB, Ortiz A, Parati G, Pontremoli R, Rossignol P, Ruilope L, Van der Niepen P, Vanholder R, Verhaar MC, Wiecek A, Wuerzner G, London GM, Zoccali C.

Nephrol Dial Transplant. 2017 Apr 1;32(4):620-640. doi: 10.1093/ndt/gfw433. Review.

PMID:
28340239
27.

Anticoagulation, atrial fibrillation, and chronic kidney disease-whose side are you on?

Heine GH, Brandenburg V.

Kidney Int. 2017 Apr;91(4):778-780. doi: 10.1016/j.kint.2016.11.028.

PMID:
28314578
28.

HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease.

Bauer L, Kern S, Rogacev KS, Emrich IE, Zawada A, Fliser D, Heinemann A, Heine GH, Marsche G.

J Am Coll Cardiol. 2017 Jan 17;69(2):246-247. doi: 10.1016/j.jacc.2016.10.054. No abstract available.

29.

MicroRNA profiling of human intermediate monocytes.

Zawada AM, Zhang L, Emrich IE, Rogacev KS, Krezdorn N, Rotter B, Fliser D, Devaux Y, Ziegler-Heitbrock L, Heine GH.

Immunobiology. 2017 Mar;222(3):587-596. doi: 10.1016/j.imbio.2016.11.006. Epub 2016 Nov 13.

PMID:
27876379
30.

Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy.

Humalda JK, Seiler-Muler S, Kwakernaak AJ, Vervloet MG, Navis G, Fliser D, Heine GH, de Borst MH.

Medicine (Baltimore). 2016 Nov;95(46):e5003.

31.

Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells.

Fell LH, Seiler-Mußler S, Sellier AB, Rotter B, Winter P, Sester M, Fliser D, Heine GH, Zawada AM.

Nephrol Dial Transplant. 2016 Nov;31(11):1835-1845. Epub 2016 Mar 24.

32.

Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis.

Federico G, Meister M, Mathow D, Heine GH, Moldenhauer G, Popovic ZV, Nordström V, Kopp-Schneider A, Hielscher T, Nelson PJ, Schaefer F, Porubsky S, Fliser D, Arnold B, Gröne HJ.

JCI Insight. 2016 Jan 21;1(1):e84916. doi: 10.1172/jci.insight.84916.

33.

Blood-Pressure and Cholesterol Lowering in the HOPE-3 Trial.

Emrich IE, Schulz DM, Heine GH.

N Engl J Med. 2016 Sep 22;375(12):1190. doi: 10.1056/NEJMc1608916. No abstract available.

PMID:
27653573
34.

NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4.

Untersteller K, Girerd N, Duarte K, Rogacev KS, Seiler-Mussler S, Fliser D, Rossignol P, Heine GH.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1978-1988. Epub 2016 Aug 11.

35.

Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis".

Weber C, Shantsila E, Hristov M, Caligiuri G, Guzik T, Heine GH, Hoefer IE, Monaco C, Peter K, Rainger E, Siegbahn A, Steffens S, Wojta J, Lip GY.

Thromb Haemost. 2016 Sep 27;116(4):626-37. doi: 10.1160/TH16-02-0091. Epub 2016 Jul 14.

PMID:
27412877
36.

Best Albuminuria Measurement to Predict Cardiovascular and Renal Events.

Bauer L, Emrich IE, Pickering JW, Untersteller K, Sandermann F, Rogacev KS, Seiler-Mussler S, Fliser D, Heine GH.

Am J Nephrol. 2016;43(5):383-8. doi: 10.1159/000446483. Epub 2016 May 18.

37.

The Kinetics of Circulating Monocyte Subsets and Monocyte-Platelet Aggregates in the Acute Phase of ST-Elevation Myocardial Infarction: Associations with 2-Year Cardiovascular Events.

Zhou X, Liu XL, Ji WJ, Liu JX, Guo ZZ, Ren D, Ma YQ, Zeng S, Xu ZW, Li HX, Wang PP, Zhang Z, Li YM, Benefield BC, Zawada AM, Thorp EB, Lee DC, Heine GH.

Medicine (Baltimore). 2016 May;95(18):e3466. doi: 10.1097/MD.0000000000003466.

38.

Hypertension in Chronic Kidney Disease Part 1: Out-of-Office Blood Pressure Monitoring: Methods, Thresholds, and Patterns.

Parati G, Ochoa JE, Bilo G, Agarwal R, Covic A, Dekker FW, Fliser D, Heine GH, Jager KJ, Gargani L, Kanbay M, Mallamaci F, Massy Z, Ortiz A, Picano E, Rossignol P, Sarafidis P, Sicari R, Vanholder R, Wiecek A, London G, Zoccali C; European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis Transplantation Association (ERA-EDTA).

Hypertension. 2016 Jun;67(6):1093-101. doi: 10.1161/HYPERTENSIONAHA.115.06895. Epub 2016 May 2. Review. No abstract available.

PMID:
27141058
39.

Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Profiles.

Parati G, Ochoa JE, Bilo G, Agarwal R, Covic A, Dekker FW, Fliser D, Heine GH, Jager KJ, Gargani L, Kanbay M, Mallamaci F, Massy Z, Ortiz A, Picano E, Rossignol P, Sarafidis P, Sicari R, Vanholder R, Wiecek A, London G, Zoccali C; European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis Transplantation Association (ERA-EDTA).

Hypertension. 2016 Jun;67(6):1102-10. doi: 10.1161/HYPERTENSIONAHA.115.06896. Epub 2016 May 2. Review. No abstract available.

PMID:
27141057
40.

DNA methylation profiling reveals differences in the 3 human monocyte subsets and identifies uremia to induce DNA methylation changes during differentiation.

Zawada AM, Schneider JS, Michel AI, Rogacev KS, Hummel B, Krezdorn N, Müller S, Rotter B, Winter P, Obeid R, Geisel J, Fliser D, Heine GH.

Epigenetics. 2016 Apr 2;11(4):259-72. doi: 10.1080/15592294.2016.1158363. Epub 2016 Mar 28.

41.

Clinical management of the uraemic syndrome in chronic kidney disease.

Vanholder R, Fouque D, Glorieux G, Heine GH, Kanbay M, Mallamaci F, Massy ZA, Ortiz A, Rossignol P, Wiecek A, Zoccali C, London GM; European Renal Association European Dialysis; Transplant Association (ERA-EDTA) European Renal; Cardiovascular Medicine (EURECA-m) working group.

Lancet Diabetes Endocrinol. 2016 Apr;4(4):360-73. doi: 10.1016/S2213-8587(16)00033-4. Epub 2016 Mar 3. Review. Erratum in: Lancet Diabetes Endocrinol. 2016 Apr;4(4):e4.

PMID:
26948372
42.

PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR.

Rogacev KS, Heine GH, Silbernagel G, Kleber ME, Seiler S, Emrich I, Lennartz S, Werner C, Zawada AM, Fliser D, Böhm M, März W, Scharnagl H, Laufs U.

PLoS One. 2016 Jan 22;11(1):e0146920. doi: 10.1371/journal.pone.0146920. eCollection 2016.

43.

External Validation of the Kidney Failure Risk Equation and Re-Calibration with Addition of Ultrasound Parameters.

Lennartz CS, Pickering JW, Seiler-Mußler S, Bauer L, Untersteller K, Emrich IE, Zawada AM, Radermacher J, Tangri N, Fliser D, Heine GH.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):609-15. doi: 10.2215/CJN.08110715. Epub 2016 Jan 19.

44.

The double challenge of resistant hypertension and chronic kidney disease.

Rossignol P, Massy ZA, Azizi M, Bakris G, Ritz E, Covic A, Goldsmith D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Ortiz A, Vanholder R, Wiecek A, Zoccali C, London GM, Stengel B, Fouque D; ERA-EDTA EURECA-m working group; Red de Investigación Renal (REDINREN) network; Cardiovascular and Renal Clinical Trialists (F-CRIN INI-CRCT) network.

Lancet. 2015 Oct 17;386(10003):1588-98. doi: 10.1016/S0140-6736(15)00418-3. Review.

PMID:
26530623
45.

slan-defined subsets of CD16-positive monocytes: impact of granulomatous inflammation and M-CSF receptor mutation.

Hofer TP, Zawada AM, Frankenberger M, Skokann K, Satzl AA, Gesierich W, Schuberth M, Levin J, Danek A, Rotter B, Heine GH, Ziegler-Heitbrock L.

Blood. 2015 Dec 10;126(24):2601-10. doi: 10.1182/blood-2015-06-651331. Epub 2015 Oct 6.

46.

Ferric pyrophosphate: good things come to those who wait?

Fell LH, Fliser D, Heine GH.

Nephrol Dial Transplant. 2015 Dec;30(12):1942-4. doi: 10.1093/ndt/gfv287. Epub 2015 Jul 21. No abstract available.

47.

Comparison of two different strategies for human monocyte subsets gating within the large-scale prospective CARE FOR HOMe Study.

Zawada AM, Fell LH, Untersteller K, Seiler S, Rogacev KS, Fliser D, Ziegler-Heitbrock L, Heine GH.

Cytometry A. 2015 Aug;87(8):750-8. doi: 10.1002/cyto.a.22703. Epub 2015 Jun 9.

48.

Mineral metabolism in heart disease.

Heine GH.

Curr Opin Nephrol Hypertens. 2015 Jul;24(4):310-6. doi: 10.1097/MNH.0000000000000129. Review.

PMID:
26050116
49.

Will too much kidney function kill you: just as none at all?

Emrich IE, Heine GH.

Nephrol Dial Transplant. 2015 Jun;30(6):869-70. doi: 10.1093/ndt/gfv126. No abstract available.

PMID:
25994656
50.

Validity of Vascular Calcification as a Screening Tool and as a Surrogate End Point in Clinical Research.

Zoccali C, Bolignano D, D'Arrigo G, Dekker FW, Fliser D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Massy Z, Ortiz A, Parati G, Rossignol P, Tripepi G, Vanholder R, Wiecek A, London G; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association–European Dialysis Transplantation Association (ERA-EDTA).

Hypertension. 2015 Jul;66(1):3-9. doi: 10.1161/HYPERTENSIONAHA.115.04801. Epub 2015 May 11. Review. No abstract available.

PMID:
25966492

Supplemental Content

Loading ...
Support Center